Medical Affairs has an AI problem. It is not the one most people think. The real challenge is not the technology. It is the reaction to it.

Across biopharma, Medical Affairs professionals at every level have met AI with hesitation, discomfort, and in many cases outright resistance. Another technology to learn. Another thing that makes the job harder. Another thing that might make the role obsolete in ten years. The fear is understandable. What is surprising is that earlier career professionals, the ones who invested most recently to build their credibility, tend to feel it the hardest. Moreover, if professionals are not avoiding AI entirely, they use it without the guardrails the field requires.

Meanwhile, a separate problem has been compounding. Early on, most department AI training available was not specific to the work that Medical Affairs does. It was mostly generic and covered how to access the approved AI tool. Most training still doesn’t account for on-label discipline, failure modes, fair balance, or the cross-functional boundaries that define how Medical Affairs actually operates.

Triple Helix Strategy was created to close these gaps. Not with generic AI guidance repurposed for Pharma, but with governance frameworks, workflows, and training built from nearly 30 years inside the constraints Medical Affairs operates within. Triple Helix Strategy exists to make Medical Affairs the most AI ready function in biopharma. Not by chasing the latest AI tools, but by building the governance infrastructure that makes AI safe, compliant, and worth the investment.

A biopharma industry where every Medical Affairs organization has the governance infrastructure to use AI confidently, compliantly, and at the pace the science demands.

Triple Helix Strategy exists to help Medical Affairs organizations adopt, scale, and optimize AI without compromising the scientific rigor and compliance standards the function is built on. Our mission is to move clients toward a Medical Affairs function that operates smarter, demonstrates measurable value, and leads the AI transition rather than reacting to it.